Abstrakt

Identification of cardiorespiratory interactions in recent years suggests that coexisting cardiac and pulmonary disease cannot be attributed solely to shared risk factors. Both, local and systemic inflammation seem to play a central role in the development of not only widespread diseases such as COPD or bronchial asthma but also rare idiopathic pulmonary fibrosis. Cardiac comorbidities are also important when evaluating patients with lung cancer or pleural effusions while cardiac sarcoidosis is increasingly understood as first manifestation of the disease. Moreover, overlapping symptoms of cardiovascular as well as pulmonary diseases such as dyspnea or chest pain often complicate differential diagnosis requiring a multidisciplinary approach.

Autoreninformation

Autoren

• F. Trinkmann¹
• I. Akin^{1, 2}
• J. Saur¹

Abteilungen

• ¹ I. Medizinische Klinik, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim der Universität Heidelberg,
• ² DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung), Standort Heidelberg/Mannheim

Adresse

PD. Dr. med. Frederik Trinkmann
I. Medizinische Klinik
Universitätsmedizin Mannheim
Theodor-Kutzer-Ufer 1 – 3
68167 Mannheim
Email: [email protected]

Citation